COMMUNIQUÉS West-GlobeNewswire

Arcutis to Report Third Quarter 2024 Financial Results and Participate in an Upcoming Investor Conference

23/10/2024 - 22:00

Quarterly investor conference call and webcast is scheduled for Wednesday, November 6 at 4:30 p.m. ET Arcutis management will also participate in the Guggenheim Securities Healthcare Innovation Conference in November [...]

Cytokinetics to Announce Third Quarter Results on November 6, 2024

23/10/2024 - 22:00

SOUTH SAN FRANCISCO, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report third quarter results on November 6, 2024 at 4:00 PM Eastern Time. [...]

BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

23/10/2024 - 21:24

CARSON CITY, Nev., Oct. 23, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions [...]

Dans le cadre de la GHE 2024, le KFSHRC célèbre 40 ans de leadership dans le domaine des cellules souches

23/10/2024 - 20:59

Plus de 7 400 greffes de cellules souches ont été réalisées RIYAD, Arabie saoudite, 23 oct. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSHRC) a fêté le 40e anniversaire de son [...]

Lung Health Foundation: New Evict Radon National Study Report Underscores ‘Urgent Need for Canada-Wide Advocacy’ to Reduce Dangerous Radon Levels in Canadian Homes

23/10/2024 - 19:30

Canada’s leading lung health organization supports and urges policy reforms through building codes, lung cancer screening and taxation policies TORONTO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The Lung Health Foundation (LHF [...]

Ancilia Biosciences Selected to Receive $3 Million Award from ARPA-H’s Sprint for Women’s Health

23/10/2024 - 19:05

—Award from Highly Competitive Initiative Will Enable Ancilia to Advance Its Lead Program through IND Filing for Its First Clinical Trial— —Ancilia Also Awarded $274,000 NIH STTR Grant to Expand Its Platform to Diseases [...]

Daré Bioscience Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health

23/10/2024 - 18:30

DARE-HPV is a potential first-in-category treatment for human papillomavirus (HPV)-related cervical disease which could change the treatment paradigm for clinical HPV management. Essentially all cervical cancer cases [...]

Saudi Surgeon Honored for Performing the World’s First Fully Robotic Heart Transplant

23/10/2024 - 18:26

"Robotic Heart Surgery" at KFSHRC…A Leading and Accelerating Journey of Success RIYADH, Saudi Arabia, Oct. 23, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) continues to set [...]

Orchard Therapeutics Announces Multiple Data Presentations and Publications

23/10/2024 - 17:30

Ten presentations at ESGCT 2024 detail the therapeutic potential and applicability of the company’s platform in rare neurometabolic diseases and beyond Nature manuscript highlights clinical results supporting long-term [...]

Le KFSHRC honore 28 scientifiques figurant sur la liste de Stanford des 2 % des chercheurs les plus cités

23/10/2024 - 17:24

En présence d’une large participation de leaders et d’experts du secteur de la santé du monde entier RIYAD, Arabie saoudite, 23 oct. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre ( [...]

BioPorto Presenting FDA-cleared ProNephro AKI (NGAL) at ASN Kidney Week 2024 Conference

23/10/2024 - 17:15

October 23, 2024 News Release BioPorto Presenting FDA-cleared ProNephro AKI (NGAL) at ASN Kidney Week 2024 Conference COPENHAGEN, Denmark and BOSTON, MA, USA, October 23, 2024, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto [...]

Rapafusyn Announces an Upcoming Oral Presentation at Targeted Protein Degradation & Induced Proximity Summit

23/10/2024 - 17:06

BALTIMORE, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Rapafusyn Pharmaceuticals is pleased to announce an upcoming oral presentation at the 7 th Targeted Protein Degradation & Induced Proximity Summit taking place from [...]

Le KFSHRC s’impose comme le plus important programme de transplantation rénale par don croisé au monde, avec 500 transplantations réussies

23/10/2024 - 16:41

Le centre consolide son rôle de leader en tant que fournisseur de solutions innovantes pour les patients atteints d’insuffisance rénale RIYAD, Arabie saoudite, 23 oct. 2024 (GLOBE NEWSWIRE) -- Dans le cadre de son [...]

KFSHRC Performs World First Robotic Left Liver Lobe Transplant

23/10/2024 - 16:40

Novel Technique Hopes to Extend Robotic Transplant to More Patients RIYADH, Saudi Arabia, Oct. 23, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) has achieved another world first [...]

Bloo Pharmapeutica Introduces Age-Defying Methylene Blue Bath Solution: Aqua Miraculorum “Water of Miracles”

23/10/2024 - 16:30

Serious Help for Aging Skin, Now Available Online and in Select Retailers Vancouver, B.C., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Bloo Pharmapeutica Inc. , an innovator in science-based health and wellness solutions, is [...]

HiberCell Receives FDA Fast Track Designation for HC-7366 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (AML)

23/10/2024 - 16:30

BOSTON, Oct. 23, 2024 (GLOBE NEWSWIRE) -- HiberCell, Inc., a clinical-stage biotechnology company developing therapeutics to address advanced cancer and cancer resistance, is pleased to announce that the U.S. Food and [...]

Cyclacel Pharmaceuticals Reports New Clinical Data from Ongoing, Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium

23/10/2024 - 15:15

- Interim data for fadraciclib monotherapy in patients with advanced solid tumors preselected for CDKN2A and/or CDKN2B abnormalities - BERKELEY HEIGHTS, N.J., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, [...]

Humber River Health Embarks on $100 Million Fundraising Mission to Cure Healthcare

23/10/2024 - 15:07

Funding to support blueprint for new high-quality, innovative models of care in Canada and beyond TORONTO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Canadians take great pride in their universal healthcare system, but with [...]

Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference

23/10/2024 - 15:00

GLEN ALLEN, Va., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and [...]